{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T12:01:38Z","timestamp":1790424098145,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100006034","name":"University of Southern California","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100006034","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIH","award":["RO1EY017293-04S1"],"award-info":[{"award-number":["RO1EY017293-04S1"]}]},{"name":"NIH","award":["RO1EY011386"],"award-info":[{"award-number":["RO1EY011386"]}]},{"name":"NIH","award":["R21EB012281"],"award-info":[{"award-number":["R21EB012281"]}]},{"name":"Norris Comprehensive Cancer Center","award":["P30 CA014089"],"award-info":[{"award-number":["P30 CA014089"]}]},{"name":"Translational Research Laboratory at the School of Pharmacy"},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"crossref","award":["IRG-58-007-48"],"award-info":[{"award-number":["IRG-58-007-48"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Cell and Tissue Imaging Core of the USC Research Center for Liver Diseases","award":["P30 DK48522"],"award-info":[{"award-number":["P30 DK48522"]}]},{"name":"Doheny Eye Institute, Advanced Imaging Core"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/j.jconrel.2013.07.016","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T16:35:14Z","timestamp":1374770114000},"page":"269-279","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"171","author":[{"given":"Mihir","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Edman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth R.","family":"Janga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jugal","family":"Dhandhukia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan G.","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Andrew","family":"MacKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah F.","family":"Hamm-Alvarez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.jconrel.2013.07.016_bb0005","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.ajo.2005.06.031","article-title":"Dry eye (Keratoconjunctivitis sicca), rheumatoid arthritis, and Sjogren's syndrome","volume":"140","author":"Lemp","year":"2005","journal-title":"Am. J. Ophthalmol."},{"issue":"1","key":"10.1016\/j.jconrel.2013.07.016_bb0010","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.exer.2005.04.019","article-title":"Male NOD mouse external lacrimal glands exhibit profound changes in the exocytotic pathway early in postnatal development","volume":"82","author":"da Costa","year":"2006","journal-title":"Exp. Eye Res."},{"issue":"10","key":"10.1016\/j.jconrel.2013.07.016_bb0015","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1167\/iovs.09-4523","article-title":"Increased expression of cathepsins and obesity-induced proinflammatory cytokines in lacrimal glands of male NOD mouse","volume":"51","author":"Li","year":"2010","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.jconrel.2013.07.016_bb0020","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s00005-009-0002-4","article-title":"Sjogren's syndrome: an old tale with a new twist","volume":"57","author":"Lee","year":"2009","journal-title":"Arch. Immunol. Ther. Exp. (Warsz.)"},{"issue":"Suppl. 1","key":"10.1016\/j.jconrel.2013.07.016_bb0025","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1834-7819.2010.01197.x","article-title":"Sjogren's syndrome: a review of aetiology, pathogenesis, diagnosis and management","volume":"55","author":"Bayetto","year":"2010","journal-title":"Aust. Dent. J."},{"issue":"1","key":"10.1016\/j.jconrel.2013.07.016_bb0030","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.matbio.2007.07.005","article-title":"Increased degradation of extracellular matrix structures of lacrimal glands implicated in the pathogenesis of Sjogren's syndrome","volume":"27","author":"Schenke-Layland","year":"2008","journal-title":"Matrix Biol."},{"issue":"11","key":"10.1016\/j.jconrel.2013.07.016_bb0035","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.1172\/JCI1158","article-title":"Cathepsin S activity regulates antigen presentation and immunity","volume":"101","author":"Riese","year":"1998","journal-title":"J. Clin. Invest."},{"issue":"2","key":"10.1016\/j.jconrel.2013.07.016_bb0040","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S1074-7613(00)80020-5","article-title":"Cathepsin S required for normal MHC class II peptide loading and germinal center development","volume":"10","author":"Shi","year":"1999","journal-title":"Immunity"},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0045","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1172\/JCI0214682","article-title":"Cathepsin S inhibitor prevents autoantigen presentation and autoimmunity","volume":"110","author":"Saegusa","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.jconrel.2013.07.016_bb0050","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1001\/jama.2010.1014","article-title":"Treatment of primary Sjogren syndrome: a systematic review","volume":"304","author":"Ramos-Casals","year":"2010","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.jconrel.2013.07.016_bb0055","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1016\/j.ophtha.2010.12.016","article-title":"Treatment of Sjogren's syndrome-associated dry eye an evidence-based review","volume":"118","author":"Akpek","year":"2011","journal-title":"Ophthalmology"},{"issue":"2","key":"10.1016\/j.jconrel.2013.07.016_bb0060","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2010.01232.x","article-title":"mTOR inhibitor-associated dermatologic and mucosal problems","volume":"24","author":"Campistol","year":"2010","journal-title":"Clin. Transplant."},{"issue":"5","key":"10.1016\/j.jconrel.2013.07.016_bb0065","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/14740338.2011.579898","article-title":"Toxicity spectrum of inhibitors of mammalian target of rapamycin in organ transplantation: etiology, pathogenesis and treatment","volume":"10","author":"Kahan","year":"2011","journal-title":"Expert Opin. Drug Saf."},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0070","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/00002281-200305000-00008","article-title":"Transplant immunosuppressant agents and their role in autoimmune rheumatic diseases","volume":"15","author":"Mayer","year":"2003","journal-title":"Curr. Opin. Rheumatol."},{"issue":"4","key":"10.1016\/j.jconrel.2013.07.016_bb0075","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.nurt.2007.08.003","article-title":"Immunosuppressive agents in multiple sclerosis","volume":"4","author":"Neuhaus","year":"2007","journal-title":"Neurotherapeutics"},{"issue":"1\u20132","key":"10.1016\/j.jconrel.2013.07.016_bb0080","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0378-5173(00)00617-7","article-title":"Solubilization of rapamycin","volume":"213","author":"Simamora","year":"2001","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.jconrel.2013.07.016_bb0085","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1097\/00007691-199512000-00020","article-title":"Rapamycin: distribution, pharmacokinetics, and therapeutic range investigations","volume":"17","author":"Yatscoff","year":"1995","journal-title":"Ther. Drug Monit."},{"key":"10.1016\/j.jconrel.2013.07.016_bb0090","first-page":"2197","article-title":"Preclinical evaluation of injectable sirolimus formulated with polymeric nanoparticle for cancer therapy","volume":"7","author":"Woo","year":"2012","journal-title":"Int. J. Nanomedicine"},{"issue":"2","key":"10.1016\/j.jconrel.2013.07.016_bb0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1166\/jbn.2012.1384","article-title":"Magnetic nanoparticles and rapamycin encapsulated into polymeric nanocarriers","volume":"8","author":"Oliveira","year":"2012","journal-title":"J. Biomed. Nanotechnol."},{"issue":"11","key":"10.1016\/j.jconrel.2013.07.016_bb0100","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/nrd3531","article-title":"Rapamycin passes the torch: a new generation of mTOR inhibitors","volume":"10","author":"Benjamin","year":"2011","journal-title":"Nat. Rev. Drug Discov."},{"issue":"7","key":"10.1016\/j.jconrel.2013.07.016_bb0105","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/j.febslet.2010.01.017","article-title":"mTOR regulation of autophagy","volume":"584","author":"Jung","year":"2010","journal-title":"FEBS Lett."},{"issue":"6","key":"10.1016\/j.jconrel.2013.07.016_bb0110","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/pro.2063","article-title":"Biodegradation of elastin-like polypeptide nanoparticles","volume":"21","author":"Shah","year":"2012","journal-title":"Protein Sci."},{"issue":"11","key":"10.1016\/j.jconrel.2013.07.016_bb0115","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1021\/bm301090x","article-title":"A tunable and reversible platform for the intracellular formation of genetically engineered protein microdomains","volume":"13","author":"Pastuszka","year":"2012","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.jconrel.2013.07.016_bb0120","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1021\/bm015630n","article-title":"Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system","volume":"3","author":"Meyer","year":"2002","journal-title":"Biomacromolecules"},{"issue":"2","key":"10.1016\/j.jconrel.2013.07.016_bb0125","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.jconrel.2011.06.010","article-title":"Design and cellular internalization of genetically engineered polypeptide nanoparticles displaying adenovirus knob domain","volume":"155","author":"Sun","year":"2011","journal-title":"J. Control. Release"},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0130","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jconrel.2013.05.013","article-title":"Elastin-based protein polymer nanoparticles carrying drug at both corona and core suppress tumor growth in vivo","volume":"171","author":"Shi","year":"2013","journal-title":"J. Control. Release"},{"issue":"4","key":"10.1016\/j.jconrel.2013.07.016_bb0135","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1021\/bm301558q","article-title":"Switchable elastin-like polypeptides that respond to chemical inducers of dimerization","volume":"14","author":"Dhandhukia","year":"2013","journal-title":"Biomacromolecules"},{"issue":"9","key":"10.1016\/j.jconrel.2013.07.016_bb0140","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1021\/bm300472y","article-title":"Elastin-like peptide amphiphiles form nanofibers with tunable length","volume":"13","author":"Aluri","year":"2012","journal-title":"Biomacromolecules"},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0145","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.exer.2009.03.020","article-title":"Altered expression of genes functioning in lipid homeostasis is associated with lipid deposition in NOD mouse lacrimal gland","volume":"89","author":"Wu","year":"2009","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.jconrel.2013.07.016_bb0150","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11523-011-0167-8","article-title":"Mechanisms of mTOR inhibitor resistance in cancer therapy","volume":"6","author":"Carew","year":"2011","journal-title":"Target. Oncol."},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0155","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0889-857X(21)00314-8","article-title":"Pathogenesis of Sjogren's syndrome","volume":"18","author":"Fox","year":"1992","journal-title":"Rheum. Dis. Clin. N. Am."},{"issue":"3","key":"10.1016\/j.jconrel.2013.07.016_bb0160","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12016-007-8011-8","article-title":"T lymphocytes in Sjogren's syndrome: contributors to and regulators of pathophysiology","volume":"32","author":"Katsifis","year":"2007","journal-title":"Clin. Rev. Allergy Immunol."},{"key":"10.1016\/j.jconrel.2013.07.016_bb0165","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1749-6632.1993.tb35855.x","article-title":"Effects of orally administered rapamycin in animal models of arthritis and other autoimmune diseases","volume":"685","author":"Carlson","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.jconrel.2013.07.016_bb0170","doi-asserted-by":"crossref","first-page":"407031","DOI":"10.1155\/2011\/407031","article-title":"Dysfunction of lacrimal and salivary glands in Sjogren's syndrome: nonimmunologic injury in preinflammatory phase and mouse model","volume":"2011","author":"Hayashi","year":"2011","journal-title":"J. Biomed. Biotechnol."},{"issue":"46","key":"10.1016\/j.jconrel.2013.07.016_bb0175","first-page":"173","article-title":"mTOR signaling: a central pathway to pathogenesis in systemic lupus erythematosus?","volume":"9","author":"Fernandez","year":"2010","journal-title":"Discov.Med."},{"issue":"4","key":"10.1016\/j.jconrel.2013.07.016_bb0180","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1096\/fj.11-194175","article-title":"Role of autophagy in immunity and autoimmunity, with a special focus on systemic lupus erythematosus","volume":"26","author":"Pierdominici","year":"2012","journal-title":"FASEB J."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913004100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365913004100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T12:18:47Z","timestamp":1688386727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365913004100"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":36,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S0168365913004100"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.07.016","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A rapamycin-binding protein polymer nanoparticle shows potent therapeutic activity in suppressing autoimmune dacryoadenitis in a mouse model of Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2013.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}